台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    41.70
  • 漲跌
    ▲0.10
  • 漲幅
    +0.24%
  • 成交量
    63
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-台灣企銀-三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀-三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/11143.6500.0043.5511890.53%
2024/04/1000.00144.1044.20-1191-0.52%
2024/04/09143.6500.0043.5511910.52%
2024/04/0800.00244.4044.20-2191-1.04%
2024/04/03143.1000.0043.1011910.52%
2024/04/02143.8000.0043.9511920.52%
2024/04/01144.30145.2544.4001930.00%
2024/03/2900.00144.5044.10-1198-0.50%
2023/12/06154.4000.0054.6011,2500.08%
2023/12/0100.00156.2055.30-11,137-0.09%
2023/11/28154.8000.0055.0011,1190.09%
2023/11/1400.00153.8054.80-11,033-0.10%
2023/11/13152.6000.0052.6011,0190.10%
2023/11/1000.00156.1054.10-11,010-0.10%
2023/11/09154.1000.0053.4019480.11%
2023/11/08156.2000.0055.4019290.11%
2023/11/07157.90159.2057.8009040.00%
2023/11/06157.4000.0057.4018610.12%
2023/11/03259.80460.4859.40-2812-0.25%
2023/11/02358.8000.0059.1037440.40%
2023/11/01259.65360.6760.40-1690-0.14%
2023/10/3100.00159.3058.80-1506-0.20%
2023/10/27149.45252.1354.40-1240-0.42%
2023/10/25245.20245.5345.0001530.00%
2023/10/2000.00144.6044.30-1138-0.72%
2023/09/25143.6000.0043.2011490.67%
2023/04/2400.00151.9051.60-1181-0.55%
2023/03/23157.3000.0057.1012690.37%
2022/09/06162.3000.0061.9013240.31%
2022/06/0100.00179.2078.70-1814-0.12%
2022/05/04187.9000.0087.2017870.13%
2022/04/28190.1000.0090.0018150.12%
2022/04/25197.0000.0096.5017790.13%
2022/04/221108.0000.00107.0017530.13%
2022/04/201107.501112.00110.0007240.00%
2022/04/1900.003112.50113.00-3657-0.46%
2022/04/1400.00186.9086.90-1523-0.19%
2022/04/13179.0000.0079.0015340.19%
2022/04/1100.00284.9585.20-2522-0.38%
2022/03/29178.3000.0078.2015610.18%
2022/03/2800.00180.5080.10-1590-0.17%
2022/03/22178.4000.0078.4017090.14%
2022/03/21180.0000.0079.8017200.14%
2022/01/2000.001100.50100.00-11,066-0.09%
2022/01/17199.2000.0099.6011,0810.09%
2022/01/1400.001103.50101.00-11,094-0.09%
2022/01/072107.2500.00104.5021,1560.17%
2022/01/0600.003108.67112.00-31,148-0.26%
2021/12/3000.002105.50104.00-21,115-0.18%
2021/12/243108.1700.00105.0031,1380.26%
2021/12/232107.001112.00112.5011,1200.09%
2021/12/222111.2500.00110.0021,1160.18%
2021/12/211118.0000.00118.5011,1210.09%
2021/12/2000.002124.00124.00-21,049-0.19%
2021/12/1700.001113.00113.00-11,039-0.10%
2021/12/14199.5000.0099.5011,0110.10%
2021/12/1300.00399.77101.50-3982-0.31%
2021/12/1000.00193.6092.50-1959-0.10%
2021/11/29191.8000.0090.5019500.11%
2021/11/2600.00291.5095.50-2955-0.21%
2021/11/25188.8000.0089.0019340.11%
2021/11/092100.751103.0098.1011,0080.10%
2021/11/081113.5000.00109.0019730.10%
2021/11/051120.0000.00119.5019450.11%
2021/11/011122.0000.00121.0019820.10%
2021/10/281125.5000.00127.5019690.10%
2021/10/221131.0000.00128.5019610.10%
2021/10/211137.0000.00136.0019530.10%
2021/10/2000.001143.00142.00-1920-0.11%
2021/10/191137.0000.00137.0019200.11%
2021/07/2300.001133.00138.50-11,509-0.07%
2021/07/211132.0000.00132.0011,4840.07%
2021/05/0500.003145.50145.50-3838-0.36%
2021/04/2600.001158.50156.00-1935-0.11%
2021/03/262170.5000.00171.5021,0070.20%
2021/03/2300.001160.00159.00-11,005-0.10%
2021/03/221158.5000.00156.5011,0110.10%
2021/03/1200.002152.00155.00-21,031-0.19%
2021/03/111149.5000.00147.5011,0410.10%
2021/03/101151.5000.00150.0011,0580.09%
2020/11/171204.5000.00202.5011,9750.05%
2020/10/231202.5000.00203.5011,8650.05%
2020/10/1900.001223.00210.00-11,871-0.05%
2020/10/161229.0000.00223.5011,8660.05%
2020/10/1500.001228.00224.50-11,900-0.05%
2020/10/131223.0000.00232.0011,9490.05%
2020/09/2200.000.2275.00275.00-0.22,182-0.01%
2020/09/1700.001245.00237.00-12,263-0.04%
2020/08/3100.002184.00172.50-22,025-0.10%
2020/08/2600.001148.00149.00-11,918-0.05%
2020/08/252149.0000.00149.5021,9260.10%
2020/08/141146.0000.00149.5012,0390.05%
2020/05/0700.00191.9090.70-1509-0.20%
2020/04/2900.00180.5082.00-1348-0.29%
2020/04/28282.7000.0082.7023080.65%
2018/03/0900.00277.8582.80-2112-1.78%
2018/03/05166.9000.0066.101681.47%
2018/02/23166.0000.0065.601661.51%
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-30天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音